GLUT1 deficiency syndrome has been characterized as a specific clinical entity encompassing neurodevelopmental impairment, movement disorders, and seizures, and it has been predominately associated with pathogenic SLC2A1 variants (Graham, 2012). This evidence concerns the gene SLC2A1 and movement disorder.